Huang Y - Search Results

1

Waste to Wealth: One-Step Exfoliating of Spent Graphite to Build a Low-Cost Cathode for Lithium-Sulfur Batteries.

Zhang Q, Hu L, Ren Y, Li J, Kong Y, Li Z, Huang Y. Zhang Q, et al. Among authors: huang y. Small. 2024 Oct 13:e2406087. doi: 10.1002/smll.202406087. Online ahead of print. Small. 2024. PMID: 39396378

2

Roboticized AI-assisted microfluidic photocatalytic synthesis and screening up to 10,000 reactions per day.

Lu JM, Wang HF, Guo QH, Wang JW, Li TT, Chen KX, Zhang MT, Chen JB, Shi QN, Huang Y, Shi SW, Chen GY, Pan JZ, Lu Z, Fang Q. Lu JM, et al. Among authors: huang y. Nat Commun. 2024 Oct 12;15(1):8826. doi: 10.1038/s41467-024-53204-6. Nat Commun. 2024. PMID: 39396057

3

Unraveling the roles and mechanisms of mitochondrial translation in normal and malignant hematopoiesis.

Liu L, Shao M, Huang Y, Qian P, Huang H. Liu L, et al. Among authors: huang y. J Hematol Oncol. 2024 Oct 12;17(1):95. doi: 10.1186/s13045-024-01615-9. J Hematol Oncol. 2024. PMID: 39396039 Review.

4

Perioperative outcomes of thoracoscopic versus non-thoracoscopic minimally invasive repair of pectus excavatum: a systematic review and meta-analysis.

Sun H, Huang Y, Han Y, Lin F. Sun H, et al. Among authors: huang y. J Cardiothorac Surg. 2024 Oct 12;19(1):603. doi: 10.1186/s13019-024-03016-y. J Cardiothorac Surg. 2024. PMID: 39396001 Free article. Review.

5

Development of predictive models for pathological response status in breast cancer after neoadjuvant therapy based on peripheral blood inflammatory indexes.

Liu S, Jiang C, Wu D, Zhang S, Qiao K, Yang X, Yu B, Huang Y. Liu S, et al. Among authors: huang y. BMC Womens Health. 2024 Oct 12;24(1):560. doi: 10.1186/s12905-024-03400-9. BMC Womens Health. 2024. PMID: 39395992

6

Mitochondrial transfer in the progression and treatment of cardiac disease.

Huang Y, Li W, Sun H, Guo X, Zhou Y, Liu J, Liu F, Fan Y. Huang Y, et al. Life Sci. 2024 Oct 10:123119. doi: 10.1016/j.lfs.2024.123119. Online ahead of print. Life Sci. 2024. PMID: 39395616 Review.

7

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Huang YJ, Ho KW, Cheng TL, Wang YT, Chao SW, Huang BC, Chao YS, Lin CY, Hsu YH, Chen FM, Chuang CH. Huang YJ, et al. Int J Biol Macromol. 2024 Oct 11;281(Pt 2):136259. doi: 10.1016/j.ijbiomac.2024.136259. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39395340 No abstract available.

8

Effects of collagen hydrolysate on the stability of anthocyanins: Degradation kinetics, conformational change and interactional characteristics.

Ren G, He Y, Liu L, Wu Y, Jiao Q, Liu J, Cai X, Zhu Y, Huang Y, Huang M, Xie H. Ren G, et al. Among authors: huang y. Food Chem. 2024 Oct 5;464(Pt 1):141513. doi: 10.1016/j.foodchem.2024.141513. Online ahead of print. Food Chem. 2024. PMID: 39395336

9

Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel predictor using interpretable machine learning.

Wang Y, Pan Z, Li S, Cai H, Huang Y, Zhuang J, Liu X, Lu X, Guan G. Wang Y, et al. Among authors: huang y. Eur J Surg Oncol. 2024 Oct 6;50(12):108738. doi: 10.1016/j.ejso.2024.108738. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39395242

10

Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapies.

Caputo J, Peddireddi A, Bhatta S, Huang Y, Bezerra E, Brammer J, Larkin K, Mims A, Vasu S, Wall S, Choe H. Caputo J, et al. Among authors: huang y. Leuk Lymphoma. 2024 Oct 12:1-8. doi: 10.1080/10428194.2024.2409876. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39394946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79,448 results

Search Page